We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHKP icon
101
Check Point Software Technologies
CHKP
$13B
– –
-26,513
Closed -$1.79M
CORT icon
102
CALL
Corcept Therapeutics
CORT
$12.4B
– –
-1,206
Closed -$124K
COST icon
103
Costco
COST
$422B
– –
-15,409
Closed -$1.72M
CRIS icon
104
Curis
CRIS
$9.78M
– –
-219
Closed -$1.24M
CYTK icon
105
CALL
Cytokinetics
CYTK
$10.5B
– –
-131
Closed -$16K
FEZ icon
106
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
– –
-83,000
Closed -$3.54M
FFIV icon
107
F5
FFIV
$22.9B
– –
-6,222
Closed -$663K
CBIO
108
Crescent Biopharma
CBIO
$537M
– –
-1,060
Closed -$1.73M
IRWD icon
109
Ironwood Pharmaceuticals
IRWD
$696M
– –
-134,306
Closed -$1.39M
LVS icon
110
Las Vegas Sands
LVS
$31.7B
– –
-27,847
Closed -$2.25M
NKE icon
111
Nike
NKE
$61.9B
– –
-99,088
Closed -$3.66M
NKTR icon
112
Nektar Therapeutics
NKTR
$2.39B
– –
-6,667
Closed -$1.21M
NVMI
113
Nova
NVMI
$12.4B
– –
-181,184
Closed -$2.03M
OEF icon
114
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-3,000
Closed -$690K
OMER icon
115
Omeros
OMER
$857M
– –
-100,000
Closed -$1.21M
PFE icon
116
CALL
Pfizer
PFE
$143B
– –
-2,108
Closed -$82K
PRGO icon
117
Perrigo
PRGO
$1.4B
– –
-36,106
Closed -$5.58M
PRTA icon
118
Prothena Corp
PRTA
$425M
– –
-55,000
Closed -$2.11M
QURE icon
119
uniQure
QURE
$3.03B
– –
-100,000
Closed -$1.55M
RDHL
120
Redhill Biopharma
RDHL
$3.95M
– –
-1,715
Closed -$2.43M
SCHW
121
Charles Schwab
SCHW
$183B
– –
-69,200
Closed -$1.89M
SILC icon
122
Silicom
SILC
$229M
– –
-32,088
Closed -$1.99M
TNXP icon
123
Tonix Pharmaceuticals
TNXP
$160M
– –
0
– -$1.04M
UTHR icon
124
United Therapeutics
UTHR
$25.8B
– –
-50,000
Closed -$4.7M
VRTX icon
125
Vertex Pharmaceuticals
VRTX
$121B
– –
-20,000
Closed -$1.4M
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.